To the Editor—We read with interest the article recently published in the Journal of Infectious Diseases by Sharp et al. [1], who investigated whether the newly discovered KI, WU, and Merkel cell polyomaviruses could persist and reactivate in immunodeficient patients. To this aim, the authors screened for the presence of genomic sequences of KI, WU, and Merkel cell polyomaviruses, in addition to BK and JC polyomaviruses, in a series of lymphoid tissue autopsy samples from immunocompromised patients with AIDS but without signs or symptoms suggestive of polyomavirus-associated diseases, such as polyomavirus-associated nephropathy or progressive multifocal leukoencephalopathy (PML), and from control subjects without AIDS. The authors demonstrated that, overall, polyomaviruses were significantly more frequently detected in immunosuppressed patients than in nonimmunosuppressed persons. In particular, with regard to the new polyomaviruses, KI polyomavirus was detected in 3 (7.1%) of 42 patients with AIDS and in 1 (1.8%) of 55 control subjects, WU polyomavirus was detected in 4 (9.5%) patients with AIDS, and Merkel cell polyomavirus was identified in only a human immunodeficiency virus (HIV)–infected injection drug user in the control group. Moreover, a higher viral load and a higher rate of mutations in the transcription control region of the viral genome were observed in immunosuppressed patients than in nonimmunosuppressed individuals with KI or WU polyomavirus infection